Pages that link to "Q34294904"
Jump to navigation
Jump to search
The following pages link to Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections? (Q34294904):
Displaying 10 items.
- Fungal endocarditis: evidence in the world literature, 1965-1995. (Q34105375) (← links)
- Invasive fungal infections: evolving challenges for diagnosis and therapeutics (Q34636544) (← links)
- Antifungal drugs used for systemic mycoses (Q35211977) (← links)
- Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety (Q35825582) (← links)
- Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosis (Q36489697) (← links)
- Treatment of invasive candidiasis in immunocompromised pediatric patients (Q37255172) (← links)
- Immunomodulatory properties of antifungal agents on phagocytic cells (Q37943851) (← links)
- Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis (Q39519018) (← links)
- Aspergillus fumigatus peritonitis in ambulatory peritoneal dialysis: a case report and notes on the therapeutic approach. (Q46548583) (← links)
- Advances in the management of invasive fungal infections in organ transplant recipients: step by step (Q74106647) (← links)